Dietary phytoestrogens: A possible role in renal disease protection

American Journal of Kidney Diseases

Volumn 37, Issue 5, 2001, Pages 1056-1068

  Velasquez, Manuel T ^a,b   Bhathena, Sam J ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Anti inflammatory effects; Antiproliferative actions; Dietary protein; Flaxseed; Hyperlipidemia; Isoflavones; Lignans; Nephropathy; Phytoestrogens; Proteinuria; Soy bean; Soy protein

Indexed keywords

DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN; MATAIRESINOL; PHYTOESTROGEN; SECOISOLARICIRESINOL;

ANTIINFLAMMATORY ACTIVITY; CELL PROLIFERATION; CLINICAL TRIAL; DIET THERAPY; HUMAN; KIDNEY DISEASE; MESANGIUM CELL; NONHUMAN; PROTEINURIA; REVIEW;

EID: 0035022816     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(05)80025-3     Document Type: Review

References (116)

1. Bright R. Cases and observations, illustrative of renal disease accompanied by the secretion of albuminous urine Guy's Hosp Rep 1 1836 338 400
2. Newburgh L.H. Production of Bright's disease through feeding high protein diets Arch Intern Med 24 1919 359 377
3. Moise T.S. Smith A.S. Effect of high protein diets on the kidneys. Experimental study Arch Pathol 4 1927 530 542
4. Newburgh L.H. Curtis A.C. Production of renal injury in the white rat by the protein of the diet. Dependence of the injury on the duration of feeding, and on the amount and kind of protein Arch Intern Med 42 1928 801 821
5. Chanutin A. Ludewig S. Experimental renal insufficiency produced by partial nephrectomy. V. Diets containing whole dried meat Arch Intern Med 58 1936 60 80
6. Blatherwick N.R. Medlar E.M. Chronic nephritis in rats fed high protein diets Arch Intern Med 59 1937 572 596
7. Farr L.E. Smadel J.E. The effect of dietary protein on the course of nephrotoxic nephritis in rats J Exp Med 70 1939 615 627
8. Smadel J.E. Farr L.E. The effect of diet on the pathological changes in rats with nephrotoxic serum nephritis Am J Pathol 15 1939 199 216
9. Brenner B.M. Meyer T.W. Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis of aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
10. Klahr S. Buerkert J. Purkerson M.L. Role of dietary factors in the progression of chronic renal disease Kidney Int 24 1983 579 587
11. Mitch W.E. Walser M. Steinman T.I. Hill S. Zeger S. Tungsanga K. The effect of a ketoacid-amino acid supplement to a restricted diet on the progression of chronic renal failure N Engl J Med 311 1984 623 629
12. Rosman J.B. ter Wee P.M. Meijer S. Piers-Becht T.P.M. Sluiter W.J. Donker A.J.M. Prospective randomized trial of early dietary protein restriction in chronic renal failure Lancet 2 1984 1291 1296
13. Ihle B.U. Becker G.J. Whitworth J.A. Charlwood R.A. Kincaid-Smith P.S. The effect of protein restriction on the progression of renal insufficiency N Engl J Med 321 1989 1773 1777
14. Fouque D. Laville M. Boissel J.P. Chifflet R. Labeeuw M. Zech P.Y. Controlled low protein diets in chronic renal insufficiency: Meta-analysis BMJ 304 1992 216 220
15. Walser M. Hill S.B. Ward L. Magder L. A crossover comparison of progression of chronic renal failure: Ketoacids versus amino acids Kidney Int 43 1993 933 939
16. Pedrini M.T. Levey A.S. Lau J. Chalmers T.C. Wang P.H. The effects of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis Ann Intern Med 124 1996 627 632
17. Williams A.J. Walls J. Metabolic consequences of differing protein diets in experimental renal disease Eur J Clin Invest 17 1987 117 122
18. Williams A.J. Baker F. Walls J. Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats Nephron 46 1987 83 90
19. Barsotti G. Navalesi R. Giampietro O. Ciardella F. Morelli E. Cupisti A. Mantovanelli A. Giovannetti S. Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with ‘overt’ diabetic nephropathyand renal insufficiency Contrib Nephrol 65 1988 87 94
20. Jibani M.M. Bloodworth L.L. Foden E. Griffiths K.D. Galpin O.P. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritionalstatus Diabet Med 8 1991 949 953
21. Wardle E.N. Soy protein diet therapy in renal disease Nephron 78 1998 328 331
22. Tomobe K. Philbrick D.J. Ogborn M.R. Takahashi H. Holub B.J. Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease Am J Kidney Dis 31 1998 55 61
23. Aukema H.M. Housini I. Rawling I.M. Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level J Am Soc Nephrol 10 1999 300 308
24. Ogborn M.R. Bankovic-Calic N. Shoesmith C. Buist R. Peeling J. Soy protein modification of rat polycystic kidney disease Am J Physiol 274 1998 F541 F549
25. Ogborn M.R. Nitschmann E. Weiler H.A. Bankovic-Calic N. Modification of polycystic kidney disease and fatty acid status by soy protein diet Kidney Int 57 2000 159 166
26. Ogborn M.R. Nitschmann E. Weiler H. Leswick D. Bankovic-Calic N. Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease Kidney Int 55 1999 417 423
27. Ingram A.J. Parbtani A. Clark W.E. Spanner E. Huff M.W. Philbrick D.J. Holub B.J. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model Am J Kidney Dis 25 1995 320 329
28. Hall A.V. Parbtani A. Clark W.R. Spanner E. Keeney M. Chin-Yee I. Philbrick D.J. Holub B.J. Abrogation of MRL/ lpr lupus nephritis by dietary flaxseed Am J Kidney Dis 22 1993 326 332
29. Theofilopolous A.N. Dixon F.I. Murine models of systemic lupus erythematosus Adv Immunol 37 1985 269 290
30. Shimokawa I. Higami Y. Hubbard G.B. McMahan C.A. Masoro E.J. Yu B.P. Diet and the suitability of the male Fischer 343 rat as a model for aging research J Gerontol 48 1993 B27 B32
31. Iwasaki K. Gleiser C.A. Masoro E.J. McMahan C.A. Seo E.I. Yu B.P. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats J Gerontol 43 1988 B5 B12
32. D'Amico G. Gentile M.G. Manna G. Fellin G. Ciceri R. Cofano F. Petrini C. Lavarda F. Perolini S. Porrini M. Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome Lancet 339 1992 1131 1134
33. Gentile M.G. Fellin G. Cofano F. Delle Fave A. Manna G. Ciceri R. Petrini C. Lavarda F. Pozzi F. D'Amico G. Treatment of proteinuric patients with a vegetarian soy diet and fish oil Clin Nephrol 40 1993 315 320
34. Soroka N. Silverberg D.S. Greemland M. Birk Y. Blum M. Peer G. Iaina A. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients Nephron 79 1998 173 180
35. Clark W.E. Parbtani A. Huff M.W. Spanner E. de Salis H. Chin-Yee I. Philbrick D.J. Holub B.J. Flaxseed: A potential treatment for lupus nephritis Kidney Int 48 1995 475 480
36. Anderson J.W. Blake J.E. Turner J. Smith B.M. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes Am J Clin Nutr 68 suppl 6 1998 S1347 S1353
37. Axelson M. Sjovall J. Gustafsson B. Setchell K.D.R. Soya—A dietary source of the non-steroidal oestrogen equol in humans and animals J Endocrinol 102 1984 49 56
38. Coward L. Barnes N.C. Setchell K.D.R. Barnes S. Genistein and daidzein, and their B-glycoside conjugates: Anti-tumor isoflavones in soy bean foods from American and Asian diets J Agric Food Chem 41 1993 1961 1967
39. Xu X. Wang H.-J. Murphy P.A. Cook L. Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women J Nutr 124 1994 825 832
40. Xu X. Harris K.S. Wang H.-J. Murphy P.A. Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women J Nutr 125 1995 2307 2315
41. Izumi T. Piskula M.K. Osawa S. Obata A. Tobe K. Saito M. Kataoka S. Kubota Y. Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans J Nutr 130 2000 1695 1699
42. King R.A. Bursill D.B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans Am J Clin Nutr 67 1998 867 872
43. Watanabe S. Yamaguchi M. Sobue T. Miura T. Arai Y. Mazur W. Wahala K. Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine, and feces of men after ingestion of 60 g baked soybean powder (kinako) J Nutr 128 1998 1710 1715
44. Zhang Y. Wang G.-J. Song T.T. Murphy P.A. Hendrich S. Urinary disposition of the soybean isoflavones, daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradationactivity J Nutr 129 1999 957 962
45. Xu X. Wang H.-J. Murphy P.A. Hendrich S. Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women J Nutr 130 2000 798 801
46. Nesbitt P.D. Lam Y. Thompson L.U. Human metabolism of mammalian lignan precursors in raw and processed flaxseed Am J Clin Nutr 69 1999 549 555
47. Axelson M. Setchell K.D.R. The excretion of lignans in rats: Evidence for an intestinal bacterial source for this new group of compounds FEBS Lett 123 1981 337 342
48. Morton M.S. Wilcox G. Wahlgvist M.L. Griffitts K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation J Endocrinol 142 1994 251 259
49. Adlercreutz H. Fotsis T. Kurzer M.S. Wahala K. Makela T. Brunow G. Hase T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, withpreliminary results in omnivorous and vegetarian women Anal Biochem 225 1995 101 108
50. Adlercreutz H. Fotsis T. Lampe J. Wahala K. Makela T. Brunow G. Hase T. Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry Scand J Clin Lab Invest 53 suppl 215 1993 S5 S18
51. Adlercreutz H. Markkanen H. Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men Lancet 342 1993 1209 1210
52. Adlercreutz H. Honjo H. Higashi A. Fotsis T. Hamalainen E. Hasegawa T. Okada H. Urinary excretion of lignans and isoflavonnoid phytoestrogens in Japanese men and women consuming traditional Japanese diet Am J Clin Nutr 54 1991 1093 1100
53. Adlercreutz H. Fotsis T. Bannwart C. Wahala K. Makela T. Brunow G. Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual habits J Steroid Biochem 25 1986 791 797
54. Kirkman L.M. Lampe J.W. Campbell D.R. Martini M.C. Slavin J.E. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets Nutr Cancer 24 1995 1 12
55. Rickard S.E. Orcheson L.J. Seidl M.M. Luyengi L. Fong H.H. Thompson L.U. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed J. Nutr 126 1996 2012 2019
56. Setchell K.D.R. Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease Rowland I.A. The Role of Gut Microflora in Toxicity and Cancer 1988 Academic New York, NY 315 345
57. Kurzer M.S. Xu X. Dietary phytoestrogens Annu Rev Nutr 17 1997 353 381
58. Setchell K.D.R. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones Am J Clin Nutr 68 suppl 6 1998 S1333 S1348
59. Tham D.M. Gardner C.D. Haskell W.L. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence J Clin Endocrinol Metab 83 1998 2223 2235
60. Messina M.J. Persky V. Setchell K.D.R. Barnes S. Soy intake and cancer risk: A review of the in vitro and in vivo data Nutr Cancer 21 1994 113 131
61. Martin P.M. Horwitz K.B. Ryan D.S. McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells Endocrinology 103 1978 1860 1867
62. Markiewicz L. Garey J. Adlercreutz H. Gurpide E. In vitro bioassays of non-steroidal phytoestrogens J Steroid Biochem Mol Biol 45 1993 399 405
63. Hirano T. Fukuoka K. Oka K. Hosaka K. Mitsuhashi H. Matsumoto Y. Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1 Cancer Invest 8 1990 595 601
64. Serraino M. Thompson L.U. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis Nutr Cancer 17 1992 153 159
65. Peterson G. Coward L. Barnes S. Isoflavones inhibit the growth of human prostate cancer cells in culture Proc Am Assoc Cancer Res 33 1992 57 64
66. Yanajihara K. Ito A. Toge T. Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract Cancer Res 53 1993 5815 5821
67. Zava D.T. Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro Nutr Cancer 27 1997 31 40
68. Wang T.T.Y. Sathyamoorthy N. Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways Carcinogenesis 17 1996 271 275
69. Kuiper G.G.J.M. Lemmen J.G. Carlsson B. Corton J.C. Safe S.H. van der Saag P.T. van der Burg B. Gustaffson J.-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology 139 1998 4252 4263
70. Akiyama T. Ishida J. Nakagawa S. Ogawara H. Watanabe S.I. Itoh N. Shibuya M. Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 1987 5592 5595
71. Okura A. Arakawa H. Oka H. Yoshinari T. Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T3 cells Biochem Biophys Res Commun 157 1988 183 189
72. Markovits J. Linassier C. Fosse P. Couprie J. Pierre J. Jacquemin-Sablon A. Saucier J.M. Le Pecq I.-B. Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II Cancer Res 49 1989 5111 5117
73. Linassier C. Pierre M. LePecq J.-B. Pierre J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity Biochem Pharmacol 39 1990 187 193
74. Fotsis T. Pepper M. Adlercreutz H. Fleischmann G. Hase T. Montesano R. Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis Proc Natl Acad Sci U S A 90 1993 2690 2694
75. Kim H. Peterson T.G. Barnes S. Mechanisms of action of the soy isoflavone genistein: Emerging role for its effects via transforming growth factor-β signaling pathways Am J Clin Nutr 68 suppl 6 1998 S1418 S1425
76. Wei H. Bowen R. Cai Q. Barnes S. Wang Y. Antioxidant and antipromotional effects of the soy bean isoflavone genistein Proc Soc Exp Biol Med 208 1995 124 130
77. Kitts D.D. Yuan Y.V. Wijewickreme A.N. Thompson L.U. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone Mol Cell Biochem 202 1999 91 100
78. Zhu Y. Lin J.H.-C. Liao H.-L. Verna L. Stemerman M.B. Activation of ICAM-I promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases Biochim Biophys Acta 1345 1997 93 98
79. Zhu Y. Lin J.H.-C. Liao H.-L. Friedli O. Jr Verna L. Marten N.W. Straus D.S. Stemerman M.B. LDL induces transcription factor activator protein-1 in human endothelial cells Arterioscler Thromb Vasc Biol 18 1998 473 480
80. Barnes P.J. Karin M. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1997 1066 1071
81. Lan Q. Mercurius K.O. Davies P.F. Stimulation of transcription factor NF-κB and AP-1 in endothelial cells subjected to shear stress Biochem Biophys Res Commun 201 1994 950 956
82. Stefanovic V. Vlahovic P. Mitic-Zlatkovic M. Epidermal growth factor upregulates aminopeptidase N and 5′-nuoleotidase in human glomerular mesangial cells Kidney Blood Press Res 21 1998 310 316
83. Kato H. Osajima A. Uezono Y. Okasaki M. Tsuda Y. Tanaka H. Oishi Y. Izumi F. Nakashima Y. Involvement of PDGF in pressure-induced mesangial cell proliferation through PKC and tyrosine kinase pathways Am J Physiol 277 1999 F105 F112
84. Hirakata M. Kaname S. Chung U.G. Joki N. Hori Y. Noda M. Takuwa Y. Okazaki T. Fujita T. Katoh T. Kurokawa K. Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells Kidney Int 51 1997 1028 1036
85. Gruden G. Thomas S. Burt D. Lane S. Chusney G. Sacks S. Viberti G. Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction Proc Natl Acad Sci U S A 94 1997 12112 12116
86. Kawata Y. Mizukam Y. Fujii Z. Sakumura T. Yoshida K. Matsuzaki M. Applied pressure enhances cell proliferation through mitogen-activated protein kinase activation in mesangial cells J Biol Chem 273 1998 16905 16912
87. Yokoo T. Kitamura M. Dual regulation of IL-1β-mediated matrix metal loproteinase-9 expression in mesangial cells by NF-IcB and AP-I Am J Physiol 270 1996 F123 F130
88. Coyne D.W. Morrison A.R. Effect of tyrosine kinase inhibitor, genistein, on interleukin-I stimulated PGE2 production in mesangial cells Biochem Biophys Res Commun 73 1990 718 724
89. Ha H. Roh D.D. Kirschenbaum M.A. Kamanna V.S. Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: Role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A J Lab Clin Med 131 1998 456 465
90. Johnson R.J. The glomerular response to injury: Progression or resolution? Kidney Int 45 1994 1769 1782
91. Floege J. Grone H.J. Progression of renal failure: What is the role of cytokines? Nephrol Dial Transplant 10 1995 1575 1586
92. Grantham J.J. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances Am J Kidney Dis 28 1996 788 803
93. Cowley B.D. Jr Gudapaty S. Kraybill A.L. Barash B.D. Harding M.A. Calvet J.P. Gattone V.H.D. Autosomal-dominant polycystic kidney disease in the rat Kidney Int 43 1993 522 534
94. Takahashi H. Calvet J.P. Dittermore-Hoover D. Yoshida K. Grantham I.J. Gattone V.H. A hereditary model of slowly progressive polycystic kidney disease in the mouse J Am Soc Nephrol 1 1991 980 989
95. Grantham J.J. Mechanisms of progression of autosomal dominant polycystic kidney disease Kidney Int 52 suppl 63 1997 S93 S97
96. Shimamura T. Morrison A.B. A progressive glomerular sclerosis occurring in five-sixths nephrectomized rats Am J Pathol 241 1975 F85 F93
97. Meyer T.W. Rennke H.G. Progressive glomerular injury after limited renal infarction in the rat Am J Pathol 241 1988 F856 F862
98. Nath K.A. Kren S.M. Hostetter T.H. Dietary protein restriction in established renal injury in the rat: Selective role of glomerular capillary pressure in progressive glomerulardysfunction J Clin Invest 78 1986 1199 1205
99. Hostetter T.H. Troy J.L. Brenner B.M. Glomerular hemodynamics in experimental diabetes mellitus Kidney Int 19 1981 410 415
100. Harris R.C. Haralson M.A. Badr K.R. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics, and metabolic activity Lab Invest 66 1992 548 553
101. Riser B.L. Cortes P. Zhao X. Bernstein J. Dumler F. Narins R.G. Intraglomerular pressure and mesangial stretch stimulate extracellular matrix formation in the rat J Clin Invest 90 1992 1932 1943
102. Grande J.P. Mechanisms of progression of renal damage in lupus nephritis: Pathogenesis of renal scarring Lupus 7 1998 604 610
103. Hansch G.M. Schieren G. Wagner C. Schonermark M. Immune damage to the mesangium: Antibody- and complement-mediated stimulation and destruction of mesangial cells J Am Soc Nephrol 2 suppl 10 1992 S139 S143
104. O'Meara Y.M. Feehally J. Salant O.J. The nephritogenic immune response Curr Opin Nephrol Hypertens 3 1994 318 328
105. Abboud H.E. Growth factors in glomerulonephritis Kidney Int 43 1993 252 267
106. Floege J. Eng E. Young B.A. Alpers C.E. Barrett T.B. Bowen-Pope D.F. Johnson R.J. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrixaccumulation in rats J Clin Invest 92 1993 2952 2962
107. Massy Z.A. Guijarro C. O'Donnell M.P. Kim Y. Kashtan C.E. Egido J. Kasiske B.L. Keane W.F. The central role of nuclear factor-κB in mesangial cell activation Kidney Int 56 suppl 71 1999 S76 S79
108. Macconi D. Noris M. Benfenati E. Quaglia R. Pagliarino G. Remuzzi G. Increased urinary excretion of platelet activating factor in mice with lupus nephritis Life Sci 48 1991 1429 1437
109. Tetta C. Bussolino F. Modena V. Montrucchio G. Segoloni G. Pescarmona G. Camussi G. Release of platelet-activating factor in systemic lupus erythematosus Int Arch Allergy Appl Immunol 1990 244 256
110. Shen T.Y. Hussaini I.M. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor Methods Enzymol 187 1990 446 454
111. Joven J. Villabona C. Masana L. Alberti R. Valles M. Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome N Engl J Med 323 1990 579 584
112. Schmitz P.G. Kasiske B.L. O'Donnell M.P. Keane W.F. Lipids and progressive renal injury Semin Nephrol 9 1989 354 369
113. Kamanna V.S. Roh D.D. Kirschenbaum M.A. Atherogenic lipoproteins: Mediators of glomerular injury Am J Nephrol 13 1993 1 5
114. Anthony M.S. Clarkson T.B. Williams J.K. Effects of soy isoflavones on atherosclerosis: Potential mechanisms Am J Clin Nutr 68 suppl 6 1998 S1390 S1393
115. Anderson J.J.B. Anthony M. Messina M. Garner S.C. Effects of phyto-oestrogens on tissues Nutr Res Rev 12 1999 75 116
116. Peterson T.G. Coward L. Kirk M. Falany C.N. Barnes S. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A Carcinogenesis 17 1996 1861 1869